S 847 – North Carolina

Status: Inactive / Dead
Year Introduced: 2022
Link: https://www.ncleg.gov/BillLookUp/2021/s%20847

Integrity in Prescription Drug Pricing Act. Enacts GS 58-3-295 to prohibit an insured’s copayment under a health benefit plan that covers insulin from exceeding $30 for a month’s supply, or a proportional copayment for another quantity, regardless of the amount or types of insulin needed. Applies to insurers and pharmacy benefits managers.

Amends GS 58-56A-3 to authorize a pharmacy or pharmacist to provide an individual for whom the pharmacy or pharmacist is filling a prescription drug information, regarding the amount an individual would pay for the drug without coverage under a health benefit plan.

Enacts GS 90-85.15C to require pharmacists to inform, or designate a supervised individual to inform, all individuals for whom the pharmacist is filling a prescription drug or device about the availability of a therapeutically equivalent brand name drug or device that is the lowest cost alternative to the prescription and the cost difference between the two.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found